Search - tctmd.com

Displaying 781 - 800 of 852

Sort: Relevancy | Date

News Industry News

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

June 04, 2013

News Daily News

Meta-analysis: Manual, Not Mechanical, Thrombectomy Holds Advantages Over PCI

May 17, 2013

News Industry News

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

April 22, 2013

News Daily News

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

L.A. McKeown

April 19, 2013

News Industry News

Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient

April 10, 2013

News Conference News ACC 2013

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

Jason Kahn

March 11, 2013

News Daily News

No Survival Difference Between One-Time, Staged PCI for Patients Without STEMI

March 09, 2013

News Conference News Cell Therapy 2013

Small Heart Failure Studies Show Positive Trends for Cell Therapy

January 27, 2013

News Conference News Cell Therapy 2013

G-CSF Shows Positive Safety, Efficacy Signals After STEMI in Preliminary Studies

January 23, 2013

News Industry News

New Clinical Trial First to Evaluate Effectiveness of CRT-P in Symptomatic Heart Failure Patients with Mild-to-Moderate Structural Heart Disease

January 09, 2013

News Daily News

EES Outperform First-Generation DES in Treatment of CTOs

L.A. McKeown

December 27, 2012

News Conference News AHA 2012

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Jason Kahn

November 04, 2012

News Conference News TCT 2012

Novel Devices for Advanced HF on Horizon

October 26, 2012

News Industry News

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

October 23, 2012

News Daily News

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

L.A. McKeown

October 18, 2012

News Conference News ESC 2012

French, European Registries Add International Flavor to TAVR Assessment

August 29, 2012

News Conference News ESC 2012

STEMI Patient Population Evolves Over 15 Years

Yael L. Maxwell

August 27, 2012

News Daily News

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

Jason Kahn

August 24, 2012

News Daily News

After TAVR, Women Show Faster LV Recovery Than Men

L.A. McKeown

June 11, 2012

News Daily News

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Caitlin E. Cox

June 07, 2012

Advertisement

Two Real-World European Studies of Abbott's Minimally Invasive MitraClip® Device Demonstrate Positive Outcomes for Patients with Mitral Regurgitation

Meta-analysis: Manual, Not Mechanical, Thrombectomy Holds Advantages Over PCI

ARCA biopharma and Medtronic to Collaborate on Atrial Fibrillation Clinical Trial for GencaroTM

Shock-Wave Preconditioning Boosts Cell Therapy for Chronic Heart Failure

Abbott's Galectin-3 Test Provides Doctors in Europe with New Tool for Assessing the Prognosis of Chronic Heart Failure Patient

Aspirin Alone Just as Good as Dual Antiplatelet Therapy Beyond 12 Months

No Survival Difference Between One-Time, Staged PCI for Patients Without STEMI

Small Heart Failure Studies Show Positive Trends for Cell Therapy

G-CSF Shows Positive Safety, Efficacy Signals After STEMI in Preliminary Studies

New Clinical Trial First to Evaluate Effectiveness of CRT-P in Symptomatic Heart Failure Patients with Mild-to-Moderate Structural Heart Disease

EES Outperform First-Generation DES in Treatment of CTOs

EMPIRE: Exenatide Cardioprotective in STEMI Patients Receiving DES

Novel Devices for Advanced HF on Horizon

Neovasc's Tiara™ transcatheter mitral valve selected as a best new device concept at TCT 2012 Scientific Symposium

Studies Show Efficacy, Relative Safety of Valve-in-Valve Technique

French, European Registries Add International Flavor to TAVR Assessment

STEMI Patient Population Evolves Over 15 Years

It’s MAGIC: Cell Therapy Reduces Long-term MACE in MI Patients

After TAVR, Women Show Faster LV Recovery Than Men

Antithrombotic Choice During PCI Influences Outcomes in Poor Clopidogrel Responders

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content